©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 419-430
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Table 2 FibroScan data
| Parameter | Pre-clinical decision support tool (n = 115) | Post-clinical decision support tool (n = 843) | P value |
| Physician ordering FibroScan (%) | < 0.0001 | ||
| Primary care | 33 | 67.1 | |
| Specialty care | 67 | 32.9 | |
| Exam probe used (%) | 0.9453 | ||
| Medium | 44.3 | 44 | |
| Extra large (XL) | 55.7 | 56 | |
| FibroScan result (%) | |||
| Fibrosis score | 0.0142 | ||
| F0 | 32.2 | 38.1 | |
| F1 | 7.8 | 14.2 | |
| F2 | 17.4 | 17.9 | |
| F3 | 13.9 | 13.3 | |
| F4 | 28.7 | 16.5 | |
| Steatosis score | < 0.0001 | ||
| S0 | 43.5 | 8.1 | |
| S1 | 4.3 | 10 | |
| S2 | 8.7 | 14.7 | |
| S3 | 43.5 | 67.3 |
- Citation: Stein L, Mittal R, Song H, Chung J, Sahota A. To scan or not to scan: Use of transient elastography in an integrated health system. World J Hepatol 2023; 15(3): 419-430
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/419.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.419